Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$OPRX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.04 down -150.00% YoY • Reported revenue of $20.5M down -29.77% YoY • OptimizeRx Corp is reiterating its fiscal year 2026 guidance, expecting revenue of $95 million to $100 million and adjusted EBITDA of $21 million to $25 million for the full year.

Price since post

Full Details

Advertisement|Remove ads.